The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2
APR 9, 202620 MIN
The Future of Healthcare with Dr. David Shulkin, former Secretary of the United States Department of Veterans Affairs Part 2
APR 9, 202620 MIN
Description
In this episode of Pharma Sessions, host Jonathan Kaskey sits down for a second time with Dr. David Shulkin, President of Shulkin Solutions, to challenge the pharmaceutical industry’s fundamental approach to drug pricing and argue that outcomes-based contracting is the path forward for sustainable profitability and patient access.What You’ll Learn:How to reframe pharma's competitive advantage from price negotiation to value-based contractingWhy the hepatitis C precedent proves outcomes-based models work at scaleThe strategic mistake pharma is making in R&D prioritizationHow to position intellectual property extensions as a trade-off for pricing transparencyWhy “a doctor and patient deciding” is a false narrative, and what actually controls accessDr. David Shulkin is a physician, healthcare executive, and the Ninth Secretary of the United States Department of Veterans Affairs. Dr. Shulkin is the only person to have led the VA healthcare system under two different presidential administrations, overseeing the nation’s largest integrated health system serving more than 9 million veterans.Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice.The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations.Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.Episode Resources:Dr. David Shulkin on LinkedInShulkin Solutions WebsiteJonathan Kaskey on LinkedInXSUNT Corporation WebsiteOr join the Pharma Sessions Substack:www.pharmasessions.substack.comPharma Sessions is handcrafted by our friends over at: fame.so